No Data
No Data
Fresenius Medical Care Resolves Legal Proceedings on Company Restructuring
Institutional Investors Control 42% of Fresenius Medical Care AG (ETR:FME) and Were Rewarded Last Week After Stock Increased 6.1%
Berenberg Bank Keeps Their Buy Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy From Goldman Sachs
Top Gap Ups and Downs on Tuesday: ACN, DB, X and More
J.P. Morgan Reaffirms Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)